Optina raises $2.1m from ADDF's diagnostics accelerator

Montreal-based diagnostics company Optina has secured $2.1 million in funding from the diagnostics accelerator at the Alzheimer's Drug Discovery Foundation.

ByIris Dorbian

25 January 2022•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Canada North America Healthcare Briefs

Optina raises $2.1m from ADDF's diagnostics accelerator

Boehringer Ingelheim Venture Fund

DigitalDX Ventures

Zoic Capital

Related articles